Venezuela uses distressed bonds to settle debts with drugmakers
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Crude Inventory Fell 3.06 Million Barrels Last Week - EIA
- US orders diplomats to depart Saudi Arabia amid Houthi strikes
Jefferies Cuts Price Target on Pfizer (PFE) to $42; Reiterates Buy
March 8, 2016 8:41 AM ESTJefferies maintained a Buy rating on Pfizer (NYSE: PFE), and cut the price target to $42.00 (from $45.00). Jefferies updated their model following the Form S-4 filing for certain LOE assumptions, as well as some fine-tuning on stand-alone operating costs and tax rate assumptions in the... More



